Companies Launch Authorized Version Of Lipofen, Generic of Malarone

In recent generic drug developments, H2-Pharma launched an authorized version of Lipofen and Mylan launched a version of Malarone.

H2-Pharma LLC June 3 announced it launched an authorized generic version of Kowa Pharmaceuticals America Inc.'s Lipofen (fenofibrate) 50 mg and 150 mg capsules.

An authorized generic drug is a branded prescription drug produced by the brand-name manufacturer and repackaged as a generic.

Lipofen is indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol, total cholesterol and triglycerides and to increase high-density lipoprotein cholesterol in adults with primary hypercholesterolemia or mixed dyslipidemia.

H2-Pharma is based in Montgomery, Ala. ...